학술논문
Outcomes of Patients With Thyroid Eye Disease Partially Treated With Teprotumumab
Document Type
Article
Author
Ho, Tiffany C.; Maamari, Robi N.; Kossler, Andrea L.; Sears, Connie M.; Freitag, Suzanne K.; Reshef, Edith R.; Shinder, Roman; Rootman, Daniel B.; Diniz, Stefania B.; Kahana, Alon; Schlachter, Dianne; Do, Thai H.; Kally, Peter; Turner, Sara; Mokhtarzadeh, Ali; Harrison, Andrew R.; Hwang, Christopher J.; Kim, Hee Joon; Avila, Sarah A.; Thomas, Dilip A.; Magazin, Maja; Wester, Sara T.; Lee, Wendy W.; Clauss, Kevin D.; Holds, John B.; Sniegowski, Matthew; Compton, Christopher J.; Briggs, Christian; Malik, Amina I.; Lucarelli, Mark J.; Burkat, Cat N.; Patel, Luv G.; Couch, Steven M.
Source
Ophthalmic Plastic and Reconstructive Surgery; March-April 2023, Vol. 39 Issue: 2 p150-155, 6p
Subject
Language
ISSN
07409303; 15372677
Abstract
Despite a national teprotumumab shortage resulting from COVID-19 pandemic, patients who were partially treated with teprotumumab achieve significant reduction in proptosis, clinical activity score, and extraocular muscle restriction and maintain these improvements during short-term interruption.